Demystifying Clinical Trials in Oncology: How to Communicate with Your Patients About Clinical Studies

Login required

Page 1 of 3: Frontmatter


Release date: November 15, 2017
Expiration date: December 31, 2018
Estimated time to complete activity: 1 hour

Program Overview
A 12- to 16-page consensus white paper that will explore the topics listed below.

  1. The current situation: clinical research in oncology today
  2. The role of the oncology nurse and nurse navigator in overcoming barriers to recruitment and facilitating patient selection/enrollment for clinical trials in oncology
  3. Best practices in navigation strategies and techniques for improving patient participation in clinical trials in oncology
  4. Special section on clinical trials with immune checkpoint inhibitors: what patients need to know

Target Audience
This activity is intended for nurse practitioners, oncology nurses, advanced practice nurses, oncology nurse navigators, and other healthcare professionals involved in managing patients with cancer.

Learning Objectives
Upon completion of the educational activity, participants should be able to:
  • Describe clinical trial options for patients with cancer, and for those who are candidates for treatment with immune checkpoint inhibitors.
  • Identify appropriate patients with cancer for clinical trials, including those that include treatment with immunotherapy.
  • Incorporate best practices in communicating information about clinical trials to cancer patients.

Featured Faculty

Name Relationship Company
Lavinia Dobrea, RN, MS, BSN, OCN
Manager, Oncology Research and Biospecimen Program
St. Joseph Hospital
The Center for Cancer Prevention and Treatment
Anaheim, CA
N/A Nothing to disclose
Joan Moore, MSN, RN, OCN, CCRP
Oncology Research Nurse
Wellspan Health
Dillsburg, PA
N/A Nothing to disclose
Name Relationship Company
Dorothy Caputo, MA, BSN, RN
CE Director of Accreditations
N/A Nothing to disclose
Bernadette Marie Makar, MSN, NP-C, APRN-C-BC
Nurse Planner
N/A Nothing to disclose
The COE Staff and Planners N/A Nothing to disclose
AKH Planners and Reviewers N/A Nothing to disclose

Criteria for Success
In order to receive credit, participants should read the monograph. Once you have read the monograph, you will continue to the online quiz and evaluation. A passing score of 70% on the quiz is required to receive credit. A statement of credit will be available upon successful completion of the quiz and evaluation at:

There is no fee for this activity.

If you have questions about this CME/CE activity, please contact AKH Inc. at:

CME/CE Credit provided by AKH Inc., Advancing Knowledge in Healthcare.

AKH Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity is awarded 1.0 Contact Hours.

Nurse Practitioners
This activity has been planned and implemented in accordance with the accreditation standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Center of Excellence Media, LLC – An affiliate of The Lynx Group. AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803
This activity is approved for 1.0 contact hour(s), which includes 0 hour(s) of pharmacology. Activity ID # 21822.

Commercial Support
This activity is supported by an educational grant from Merck Sharp & Dohme Corp. and AstraZeneca Pharmaceuticals LP. These educational grants are for the educational portion of the program only.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.

Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.

Login required